DAX23.630 -1,5%ESt505.326 -1,8%Top 10 Crypto14,67 +0,8%Dow41.603 -0,6%Nas18.737 -1,0%Bitcoin94.421 -0,4%Euro1,1367 ±0,0%Öl65,03 +1,6%Gold3.360 ±0,0%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 RENK RENK73 BASF BASF11 Siemens Energy ENER6Y BYD A0M4W9 Apple 865985 Tesla A1CX3T Mercedes-Benz Group (ex Daimler) 710000 Allianz 840400 Deutsche Bank 514000 D-Wave Quantum A3DSV9 Infineon 623100 Deutsche Telekom 555750 Lufthansa 823212
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen gehen mit Verlusten ins Wochenende -- DAX geht weit unter 24.000er-Marke ins Wochenende -- IonQ und D-Wave im Blick -- Meta, Apple, Reddit, Amazon, Rheinmetall im Fokus
Top News
Internetplattform X mit kurzzeitiger Störung Internetplattform X mit kurzzeitiger Störung
KW 21: So performten die MDAX-Aktien in der vergangenen Woche KW 21: So performten die MDAX-Aktien in der vergangenen Woche
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Anixa Biosciences Aktie

NeuKaufenVerkaufen
Aktien-Sparplan anlegen
2,14 EUR -0,10 EUR -4,46 %
STU
2,49 USD -0,09 USD -3,49 %
nachbörslich
BTT
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN
Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handelnSmartphone

Marktkap.70,81 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA2N6ZF

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS03528H1095

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolANIX

Anixa Biosciences Aktien News

DatumMeistgelesen
PR NewswireAnixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines
PR NewswireAnixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
PR NewswireAnixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024
PR NewswireAnixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
PR NewswireAnixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
PR NewswireAnixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
PR NewswireAnixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference
PR NewswireAnixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024
PR NewswireAnixa Biosciences to Present at Biotech Showcase 2024
PR NewswireAnixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine
PR NewswireAnixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine
PR NewswireAnixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference
PR NewswireAnixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board
PR NewswireAnixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences Establishes Cancer Business Advisory Board
PR NewswireAnixa Biosciences to Participate in September Investor Conferences
PR NewswireAnixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit
PR NewswireAnixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial
PR NewswireAnixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology
PR NewswireAnixa Biosciences Announces Issuance of Canadian Patent for its CAR-T Cancer Therapy Technology
PR NewswireAnixa Biosciences Announces Treatment of Second Patient in its Ovarian Cancer CAR-T Clinical Trial
PR NewswireAnixa Biosciences Clarifies Poster Presentation on Company Website
PR NewswireAnixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
PR NewswireAnixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2023 AACR Annual Meeting
PR NewswireAnixa Biosciences Reassures Shareholders It Has No Accounts at Silicon Valley Bank
PR NewswireAnixa Biosciences to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
PR NewswireAnixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine Technology
PR NewswireAnixa Biosciences Announces Formation of Breast Cancer Clinical Advisory Board
PR NewswireAnixa Biosciences to Present at Biotech Showcase 2023
PR NewswireAnixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccine
PR NewswireAnixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
PR NewswireDr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapy
PR NewswireAnixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinic
Wer­bung

Anixa Biosciences News

Anixa Biosciences News: auf dieser Seite finden Sie alle Anixa Biosciences News und Nachrichten zur Anixa Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Anixa Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Anixa Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.